Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05192031
Other study ID # START
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 9, 2022
Est. completion date June 30, 2025

Study information

Verified date June 2024
Source Vejle Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 295
Est. completion date June 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Referred to lung cancer workup at participating hospital - Able to speak and understand Danish Exclusion Criteria: - Unable to complete electronic questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Smoking cessation support
Training healthcare professionals to deliver smoking cessation support as part of hospital-based lung cancer workup.

Locations

Country Name City State
Denmark Vejle Hospital Vejle

Sponsors (9)

Lead Sponsor Collaborator
Vejle Hospital Aalborg University Hospital, Aarhus University Hospital, Bispebjerg Hospital, Hospital of Southern Jutland, Naestved Hospital, Odense University Hospital, University Hospital, Gentofte, Copenhagen, Zealand University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients making an attempt at smoking cessation during lung cancer workup Binary outcome (Attempt: yes, no) 6 weeks after baseline
Secondary Motivation to quit smoking Numeric rating scale (0-10) with higher score indicating stronger motivation 6 weeks, 3, 6, and 12 months after baseline
Secondary Proportion of patients who are not smoking at the time of measurement Binary outcome (Currently smoking: yes, no) 6 weeks, 3, 6, and 12 months after baseline
Secondary Quality of life as measured by the 36 item Short Form Survey (SF-36) SF-36, two components: Mental and Physical. Each components scale has a total score range from 5 (worst health) to 80 (best health) 6 weeks, 3, 6, and 12 months after baseline
Secondary Psychosocial consequences of lung cancer workup Consequences of Screening - Lung Cancer Questionnaire (adapted to the lung cancer workup setting). Items in Part 1 of the questionnaire focuses on experiences during the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 72 (high level of psychosocial consequences). Items in Part 2 of the questionnaire focuses on experiences after the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 22 (high level of psychosocial consequences). 6 weeks after baseline
Secondary Hospitals' number of referrals to municipality-based smoking cessation programmes Change from one year before to one year after intervention
See also
  Status Clinical Trial Phase
Completed NCT02060877 - Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease N/A